Microbiota: a key orchestrator of cancer therapy. (Q39183428)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

title

Microbiota: a key orchestrator of cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Giorgio Trinchieri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

language of work or name

English

0 references

publication date

17 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

271-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc.2017.13

6 April 2020

exact match

0 references

cites work

The application of ecological theory toward an understanding of the human microbiome

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Metaorganisms as the new frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The role of the microbiota in inflammation, carcinogenesis, and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Nutritional Keys for Intestinal Barrier Modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal epithelial cells: regulators of barrier function and immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Compartmentalized and systemic control of tissue immunity by commensals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Role of the microbiota in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Revised Estimates for the Number of Human and Bacteria Cells in the Body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Pathobionts of the gastrointestinal microbiota and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Host microbiota constantly control maturation and function of microglia in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut microbiota promote hematopoiesis to control bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Modulation of the human gut microbiota by dietary fibres occurs at the species level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Epithelial crosstalk at the microbiota-mucosal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The long-term stability of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Temporal Stability of the Human Skin Microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Human genetics shape the gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Host lifestyle affects human microbiota on daily timescales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

A history of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Subcellular targets of cisplatin cytotoxicity: an integrated view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Transforming berberine into its intestine-absorbable form by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Xenobiotics shape the physiology and gene expression of the active human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Chemotherapy-driven dysbiosis in the intestinal microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut microbiome interactions with drug metabolism, efficacy, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Developing a metagenomic view of xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal microbiota regulate xenobiotic metabolism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The effect of gut microbiota on drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Pharmacogenetics of irinotecan disposition and toxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Local bacteria affect the efficacy of chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Systems biology of cisplatin resistance: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Sound preconditioning therapy inhibits ototoxic hearing loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

DNA damage response in cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Chemotherapy-induced peripheral neurotoxicity: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immune adaptations that maintain homeostasis with the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

TLR signaling modulates side effects of anticancer therapy in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The interaction of gut microbes with host ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

(1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbiota-induced obesity requires farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Inflammation- and tumor-induced anorexia and weight loss require MyD88 in hematopoietic/myeloid cells but not in brain endothelial or neural cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbiota depletion promotes browning of white adipose tissue and reduces obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Systemic Inflammation in Cachexia - Is Tumor Cytokine Expression Profile the Culprit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cancer Cachexia: Beyond Weight Loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Influence of cancer cachexia on drug liver metabolism and renal elimination in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Muscle wasting: the gut microbiota as a new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The radiation-induced bystander effect: evidence and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Trial Watch: Anticancer radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Systemic mechanisms and effects of ionizing radiation: A new 'old' paradigm of how the bystanders and distant can become the players.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The non-targeted effects of radiation are perpetuated by exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbiome and Anticancer Immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Low-dose irradiation affects the functional behavior of oral microbiota in the context of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal microbiota-derived metabolomic blood plasma markers for prior radiation injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Trial Watch: Toll-like receptor agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Use of probiotics for prevention of radiation-induced diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbial regulation of intestinal radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Angiopoietin-Like Proteins: A Comprehensive Look

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Circadian transitions in radiation dose-dependent augmentation of mRNA levels for DNA damage-induced genes elicited by accurate real-time RT-PCR quantification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal microbiota reduces genotoxic endpoints induced by high-energy protons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Breakthrough of the year 2013. Cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Trained immunity: A program of innate immune memory in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Therapeutic vaccines in solid tumours: can they be harmful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immune modulation in cancer with antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Mouse models in oncoimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immunological Consequences of Intestinal Fungal Dysbiosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The virome in host health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Helminth infection promotes colonization resistance via type 2 immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Structure of the gut microbiome following colonization with human feces determines colonic tumor burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

21 January 2018

The price of immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Colorectal cancer: CRC--all about microbial products and barrier function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbes, microbiota, and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Allogeneic hematopoietic cell transplantation: the state of the art

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Role of intestinal microbiota in transplantation outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Systemic effects of gut microbiota and its relationship with disease and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Immunoproliferative small intestinal disease associated with Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gut bacteria require neutrophils to promote mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Innate immune recognition of the microbiota promotes host-microbial symbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Animals in a bacterial world, a new imperative for the life sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Initial symbiont contact orchestrates host-organ-wide transcriptional changes that prime tissue colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Patterns of early gut colonization shape future immune responses of the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Effects of vitamin K-active compounds and intestinal microorganisms in vitamin K-deficient germfree rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Aging in Germ-free Mice: Life Tables and Lesions Observed at Natural Death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Gastrointestinal toxicity of chemotherapeutic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Phylogenetic distribution of genes encoding β-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Beneficial bacteria inhibit cachexia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Diurnal variation in the response of gamma-ray-induced apoptosis in the mouse intestinal epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Diurnal variations in the expression of radiation-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

An enteric virus can replace the beneficial function of commensal bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Resurrection of endogenous retroviruses in antibody-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.13

31 March 2020

Identifiers

DOI

10.1038/NRC.2017.13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303904%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference